[Individual laboratory control of anticoagulant therapy].
Spannagl
M
M
Medizinische Klinik, Klinikum Innenstadt der LMU, München.
Lill
H
H
Trauner
A
A
Schramm
W
W
D000925:Anticoagulants / Q000008:administration & dosage*; D001780:Blood Coagulation Tests; D004305:Dose-Response Relationship, Drug; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D012008:Recurrence; D012307:Risk Factors; D013924:Thrombophlebitis / Q000097:blood / Q000517:prevention & control*; D013927:Thrombosis / Q000097:blood / Q000517:prevention & control*
D000925:Anticoagulants; D005338:Fibrin Fibrinogen Degradation Products; C011468:fibrinmonomer; D006493:Heparin
Individuelle Laborkontrolle gerinnungshemmender Therapien.